puromycin aminonucleoside has been researched along with DDD MPGNII in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eitner, F; Floege, J; Henninger, DD; Janjic, N; Kerjaschki, D; Kunter, U; Loos, A; Ostendorf, T; Regele, H | 1 |
| Gejyo, F; Ikezumi, Y; Ito, Y; Kawachi, H; Koike, H; Morioka, Y; Oyanagi, A; Shimizu, F | 1 |
2 other study(ies) available for puromycin aminonucleoside and DDD MPGNII
| Article | Year |
|---|---|
VEGF(165) mediates glomerular endothelial repair.
Topics: Aneurysm; Animals; Cell Division; Cornea; Endothelial Growth Factors; Endothelium, Vascular; Glomerulonephritis; Glomerulonephritis, Membranoproliferative; Humans; Kidney Glomerulus; Lymphokines; Male; Neovascularization, Physiologic; Polyethylene Glycols; Protein Isoforms; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Sprague-Dawley; Rats, Wistar; Renal Circulation; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1999 |
Podocyte injuries exacerbate mesangial proliferative glomerulonephritis.
Topics: Animals; Antibodies, Monoclonal; Female; Glomerular Mesangium; Glomerulonephritis, Membranoproliferative; Kidney; Puromycin Aminonucleoside; Rats; Rats, Wistar; Thy-1 Antigens; Time Factors | 2001 |